Hypomethylation of DAPL1 associated with prognosis of lung cancer patients with EGFR Del19 mutation
10.3760/cma.j.cn112152-20190923-00618
- VernacularTitle:凋亡相关蛋白激酶样蛋白1低甲基化对表皮生长因子受体19外显子缺失突变型肺癌患者预后的影响
- Author:
Yangyang FENG
1
;
Yan YANG
;
Yanyang WANG
;
Xuehong BAI
;
Ping HAI
;
Ren ZHAO
Author Information
1. 宁夏医科大学总院肿瘤医院放疗科，银川 750004
- Keywords:
Lung neoplasms;
Death associated protein like-1;
Epidermal growth factor receptor;
Exon 19 deletion mutation;
Prognosis
- From:
Chinese Journal of Oncology
2021;43(12):1264-1268
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To investigate the effect of apoptosis-associated protein kinase-like 1 (DAPL1) hypomethylation on prognosis of lung cancer patients with epidermal growth factor receptor gene exon 19 deletion (EGFR Del19) mutation.Methods:The clinicopathological data of lung cancer patients in databases of genomic data sharing (GDC) TCGA lung adenocarcinoma, TCGA lung adenocarcinoma, and TCGA lung cancer were collected to analyze the effect of DAPL1 methylation level on the prognosis of patients with EGFR Del19 mutation. Linear regression model was used for correlation analysis, Kaplan-Meier method was used to draw the survival curve, and the difference of survival curve between the two groups was tested by Log rank.Results:In GDC TCGA lung adenocarcinoma, TCGA lung adenocarcinoma and TCGA lung cancer databases, the 5-year survival rates of lung cancer patients with high DAPL1 expression (31.9%, 27.5% and 33.0%, respectively) were higher than those with low DAPL1 expression (11.0%, 11.6% and 13.8%, respectively). The differences were statistically significant ( P=0.006, 0.028 and 0.025, respectively). The median expression levels of DAPL1 in patients with EGFR Del19 mutation (12.8, 2.75 and 2.9, respectively) were higher than those in patients with other EGFR mutations (11.6, 1.75 and 1.8, respectively, P<0.05). In TCGA lung adenocarcinoma and TCGA lung cancer database, the 5-year survival rate of lung cancer patients with lower DAPL1 methylation levels (22.4% and 16.4%, respectively) were higher than those of lung cancer patients with higher DAPL1 methylation levels (15.1% and 14.2%, respectively), with statistical significance ( P<0.05). The expression level of DAPL1 was positively correlated with the EGFR mutant subtype ( r=0.909, P<0.05), and negatively correlated with DNA methylation ( r=-0.891, P<0.05). The expression of DAPL1 in lung cancer patients was regulated by DNA methylation, which affected the prognosis of lung cancer patients. Conclusion:High DAPL1 expression, or hypomethylation, is associated with lung cancer EGFR Del19 mutation subtype, and DAPL1 hypomethylated lung cancer patients have longer overall survival.
